Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erkang Fan

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|February 2, 2011
Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in MiceSayaka Shibata, J Robert Gillespie, Angela M Kelley, et al.
International Journal for Parasitology|October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapyKayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
The Journal of Infectious Diseases|May 26, 2017
Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium InfectionSamuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
International Journal of Antimicrobial Agents|July 25, 2020
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in miceNicoleta Anghel, Pablo A Winzer, Dennis Imhof, et al.
The Journal of Infectious Diseases|April 20, 2026
Effective Treatment using Bumped Kinase Inhibitor 1708 in a Calf Clinical Model of CryptosporidiosisDeborah A Schaefer, Dana P Betzer, Kevin Ackman, et al.
Journal of Biomolecular Screening|May 28, 2009
Buffer optimization of thermal melt assays of Plasmodium proteins for detection of small-molecule ligandsGregory J Crowther, Alberto J Napuli, Andrew P Thomas, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2021
Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of InfectionMuhammad M Hasan, Erin E Stebbins, Robert K M Choy, et al.
Journal of Medicinal Chemistry|February 11, 2012
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activitySteven M Johnson, Ryan C Murphy, Jennifer A Geiger, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> InfectionFrederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.
The Journal of Infectious Diseases|November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against ToxoplasmosisMatthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|February 2, 2011
Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in MiceSayaka Shibata, J Robert Gillespie, Angela M Kelley, et al.
International Journal for Parasitology|October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapyKayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
The Journal of Infectious Diseases|May 26, 2017
Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium InfectionSamuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
International Journal of Antimicrobial Agents|July 25, 2020
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in miceNicoleta Anghel, Pablo A Winzer, Dennis Imhof, et al.
The Journal of Infectious Diseases|April 20, 2026
Effective Treatment using Bumped Kinase Inhibitor 1708 in a Calf Clinical Model of CryptosporidiosisDeborah A Schaefer, Dana P Betzer, Kevin Ackman, et al.
Journal of Biomolecular Screening|May 28, 2009
Buffer optimization of thermal melt assays of Plasmodium proteins for detection of small-molecule ligandsGregory J Crowther, Alberto J Napuli, Andrew P Thomas, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2021
Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of InfectionMuhammad M Hasan, Erin E Stebbins, Robert K M Choy, et al.
Journal of Medicinal Chemistry|February 11, 2012
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activitySteven M Johnson, Ryan C Murphy, Jennifer A Geiger, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> InfectionFrederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.
The Journal of Infectious Diseases|November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against ToxoplasmosisMatthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Pageof 11